Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Emerging Toxicities, Translational Research and Reverse Cardio-oncology
Author(s): Massimiliano Camilli , Luca Maggio , Lorenzo Tinti , et al Added: 1 year ago

CV Disease in Special Populations

Heart Failure
ESC 25: Cardio-oncology Highlights with Dr Susan Dent
Author(s): Susan Dent Added: 7 months ago
ESC Congress 2025 – Dr Susan Dent (University of Rochester, US) joins us to discuss cardio-oncology highlights from this year's conference.Recorded on-site at ESC Congress 2025, Madrid.Editors: Jordan Rance, Yazmin SadikVideo Specialists: Dan Brent, Tom Green, Mike Knight, Oliver Miles, David Ben-Harosh. View more

CV Disease in Special Populations
Frailty and Cardio-oncology
Author(s): Erkihun Amsalu , Tan Van Nguyen , Harry Klimis , et al Added: 4 months ago

CV Disease in Special Populations
Frailty in Cardio-oncology
Author(s): Ilaria Torre , Lorenzo Tinti , Ludovica Amore , et al Added: 2 months ago

CV Disease in Special Populations

Heart Failure
Anticoagulation in Cardio-oncology
Author(s): Sebastian Szmit , Maciej Krzakowski , Dariusz M Kowalski , et al Added: 1 month ago

Anticoagulation

CV Disease in Special Populations
ICOS
IC-OS exists to advance cardiovascular care of cancer patients and survivors by promoting collaboration among researchers, educators and clinicians around the world. Become a member here. Visit: https://members.ic-os.org/general/register_member_type.asp? View more
New Horizons in Cardio Kidney Disease
Author(s): Muthiah Vaduganathan, Neha Pagidipati, Smeeta Sinha Start date: Jun 30, 2026
Join us for New Horizons in Cardio Kidney Disease, a new one-day virtual educational event taking place on 30 June 2026. This programme is designed to address current challenges in cardio-kidney care through practical, cross-disciplinary education, with a focus on biomarker-guided risk assessment, optimisation of blood pressure and cardio-kidney therapies, and emerging multimodal strategies.The… View more

Cardiovascular Kidney Metabolic
3 ACC.26 Highlights for the Cardiology Pharmacist
Author(s): Craig Beavers Added: 1 week ago
ACC 2026 — In this ISCP-partnered highlights video, Dr Craig Beavers (University of Kentucky College of Pharmacy, Lexington, KY, USA) brings a clinical pharmacist's perspective to ACC.26, spotlighting the three developments most relevant to cardiology pharmacists and the expanding role of pharmacy in cardiovascular care.Produced in collaboration with the International Society of Cardiovascular… View more

Electrophysiology & Arrhythmia

Heart Failure
Margot K Davis
Job title: Director, University of British Columbia (UBC) Cardiology-Oncology Program, Vancouver General Hospital, Vancouver, Canada
Dr Margot Davis is a cardiologist at Vancouver General Hospital and St. Paul's Hospital, as well as the director of the UBC Cardiology-Oncology Program and a clinical assistant professor at the University of British Columbia (UBC). Dr Davis is a key panel member of the CCS Cardio-Oncology Guidelines, a secondary panel member of the CCS Heart Failure Guidelines, and co-chair of the CCS/CHFS… View more
Navin Mathiyalagan
Job title: Medical Oncologist
Dr Navin Mathiyalagan is a Medical Oncologist at Nottingham University Hospitals, with a special interest in ca dio-oncology. He completed medical school and Internal Medicine training in India followed by MRCP and Medical Oncology training in the UK. He is actively involved in developing cardio-oncology services in Nottingham and across the Midlands to improve care for patients receiving cancer… View more